НовостиBenzingaFDA Clears Satellos Bioscience’s IND Application For Forazapadin For Treatment Of Facioscapulohumeral Muscular Dystrophy FDA Clears Satellos Bioscience’s IND Application For Forazapadin For Treatment Of Facioscapulohumeral Muscular Dystrophy Benzinga 2026.09.24 11:01 (GMT+0) Открыть на Benzinga Другие новости